Spectrum Pharma sells marketed portfolio for $160 million upfront, up to $140 million in milestone payments

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Spectrum Pharmaceuticals Inc. said Thursday it has reached an agreement to sell its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma L.L.C. Spectrum said it will receive $160 million in an upfront cash payment and be entitled to up to $140 million milestone payments on reaching certain regulatory and sales goals. The company said its staff will be reduced by about 40% with most transitioning to Acrotech. The remaining staff will focus on the launch of it two late-stage pipeline treatments, ROLONTIS and poziotinib, which are cancer drugs. Shares were halted for the news, but have fallen 46.1% in the last 12 months, while the S&P 500 has fallen 6.7%.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Samsung Faces Resistance From Big Pharma in the U.S.Samsung’s foray into the U.S. biologic-drug market is proving tougher than expected, as the South Korean company faces strong resistance from established pharmaceutical companies while doctors and patients are reluctant to switch to biosimilars. I assume patents as well The margins aren't there either. Like regular drugs the cost of manufacturing is usually a fraction of 1% of the price so there's a lot of value capture. With biologics it's 66% so there's not as much value to capture for biosimilars. Totally worth it if the medication gets me looking like 👇
Source: WSJ - 🏆 98. / 63 Read more »

Would Big Pharma Pay for the Wall?Ensuring the federal government reopens soon is very much in the pharmaceutical industry’s interest. Absent a deal, the FDA will run out of funds to process applications for new drugs. . let all be realistic here off course one needs the other to co-operate ! Shut down is because the Democrats would rather have our society threatened than work out a deal. The Democrats have politically decided they are far more important than joe citizen No, they are so greedy with their money
Source: WSJ - 🏆 98. / 63 Read more »

U.S. lawmaker launches investigation into pharma drug pricingA top U.S. lawmaker launched an investigation into pharmaceutical industry prici... In the meantime, he should investigate how much Cory Booker took in from big pharma. Will this be a priority of His ? Drug pricing is a National issue and Needs Deep Investigation. ABC FoxNews CBSNews
Source: Reuters - 🏆 2. / 97 Read more »